Literature DB >> 8295787

Comparisons between microvascular changes in cerebral and non-cerebral malaria in mice, using the retinal whole-mount technique.

A L Neill1, T Chan-Ling, N H Hunt.   

Abstract

CBA/T6 mice inoculated with Plasmodium berghei ANKA strain (PbA) exhibited cerebral symptoms and died from cerebral malaria 6-8 days p.i. whereas DBA/2J mice developed (around days 6-9) a non-fatal cerebral malaria, with milder cerebral symptoms, and died between days 15 and 22 from other malaria-related complications. When inoculated with P. berghei K173 (Pb) these mouse strains did not develop cerebral malaria. These mouse/parasite strain combinations were used, in conjunction with the retinal whole-mount technique, to elucidate factors critical in the pathology of murine cerebral malaria. CBA/T6 mice infected with PbA (PbA-CBA mice) demonstrated mild changes in vascular permeability as early as days 2-3, prior to the appearance on day 5 of cerebral symptoms, whereas mice with non-cerebral malaria did not show any vascular permeability changes until the very late stage of the disease (days 14-22). In the PbA infections, progressive deterioration of endothelial barrier properties, demonstrated by Evans' Blue leakage both generally and from specific focal areas, as well as a developing monocytosis and adherence of mononuclear cells to the endothelium of the retinal vessels continued until death (in CBA/T6 mice) or resolution (in DBA/2J mice). Adherent monocytes, particularly in PbA-CBA mice, were associated with reduced Hoechst staining of individual endothelial cells and a banking up proximally of both parasitized and non-parasitized blood cells in the small blood vessels, often with accompanying focal leakage of Evans' Blue from the retinal vessels. The occurrence and severity of these early changes in the microcirculation correlated with the subsequent development of cerebral symptoms. Monocyte margination appeared to be the most significant factor associated with the development of cerebral symptoms.

Entities:  

Mesh:

Year:  1993        PMID: 8295787     DOI: 10.1017/s0031182000068050

Source DB:  PubMed          Journal:  Parasitology        ISSN: 0031-1820            Impact factor:   3.234


  18 in total

1.  Assessing vascular permeability during experimental cerebral malaria by a radiolabeled monoclonal antibody technique.

Authors:  H C van der Heyde; P Bauer; G Sun; W L Chang; L Yin; J Fuseler; D N Granger
Journal:  Infect Immun       Date:  2001-05       Impact factor: 3.441

2.  Reactive changes of retinal microglia during fatal murine cerebral malaria: effects of dexamethasone and experimental permeabilization of the blood-brain barrier.

Authors:  I M Medana; T Chan-Ling; N H Hunt
Journal:  Am J Pathol       Date:  2000-03       Impact factor: 4.307

3.  Cerebral malaria pathogenesis: what can we learn from microarray analysis?

Authors:  Chandy C John
Journal:  Am J Pathol       Date:  2007-11-08       Impact factor: 4.307

4.  Correlation between enhanced vascular permeability, up-regulation of cellular adhesion molecules and monocyte adhesion to the endothelium in the retina during the development of fatal murine cerebral malaria.

Authors:  N Ma; N H Hunt; M C Madigan; T Chan-Ling
Journal:  Am J Pathol       Date:  1996-11       Impact factor: 4.307

Review 5.  How malaria has affected the human genome and what human genetics can teach us about malaria.

Authors:  Dominic P Kwiatkowski
Journal:  Am J Hum Genet       Date:  2005-07-06       Impact factor: 11.025

6.  Tumor necrosis factor-alpha expression in the brain during fatal murine cerebral malaria: evidence for production by microglia and astrocytes.

Authors:  I M Medana; N H Hunt; G Chaudhri
Journal:  Am J Pathol       Date:  1997-04       Impact factor: 4.307

Review 7.  Pathogenesis of cerebral malaria: recent experimental data and possible applications for humans.

Authors:  J Lou; R Lucas; G E Grau
Journal:  Clin Microbiol Rev       Date:  2001-10       Impact factor: 26.132

8.  Susceptibility to experimental cerebral malaria induced by Plasmodium berghei ANKA in inbred mouse strains recently derived from wild stock.

Authors:  S Bagot; M Idrissa Boubou; S Campino; C Behrschmidt; O Gorgette; J-L Guénet; C Penha-Gonçalves; D Mazier; S Pied; P-A Cazenave
Journal:  Infect Immun       Date:  2002-04       Impact factor: 3.441

9.  Evidence for multiple pathologic and protective mechanisms of murine cerebral malaria.

Authors:  V M Jennings; A A Lal; R L Hunter
Journal:  Infect Immun       Date:  1998-12       Impact factor: 3.441

10.  Loss of ability to self-heal malaria upon taurine transporter deletion.

Authors:  Denis Delic; Ulrich Warskulat; Elena Borsch; Saad Al-Qahtani; Saleh Al-Quraishi; Dieter Häussinger; Frank Wunderlich
Journal:  Infect Immun       Date:  2010-01-25       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.